# A Trial of PF-06252616 in Ambulatory Participants With LGMD2I

> **NCT02841267** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kathryn Wagner** · enrollment: 19 (actual)

## Conditions studied

- LGMD2I

## Interventions

- **DRUG:** PF 06252616

## Key facts

- **NCT ID:** NCT02841267
- **Lead sponsor:** Kathryn Wagner
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02841267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02841267, "A Trial of PF-06252616 in Ambulatory Participants With LGMD2I". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02841267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*